Avidity Biosciences Director Sells $3.8M in Stock by Mark Eisenberg 15.06.2024 Arthur A. Levin sells 40K Avidity shares; BofA ups target to $45 as FDA advances myotonic dystrophy treatment. AI-assisted article ...
Tempus AI Raises $410M in IPO, Sees Revenue Surge by Mark Eisenberg 15.06.2024 Tempus AI sold 11M shares at $37 each, launched in 2015, focuses on medical testing, with revenue growth from $320.7M ...
Novo Nordisk CEO to Testify on High Prices of Ozempic, Wegovy by Mark Eisenberg 15.06.2024 Senate subpoenas Novo's Langa over drug pricing; Jorgensen to testify in September as Novo blames U.S. health system for high ...
Altimmune’s Promising GLP-1 Drug: Worth the Investment? by Mark Eisenberg 25.04.2024 Altimmune's stock has seen a strong increase in value, surpassing Eli Lilly and Novo Nordisk. However, there are risks involved.
Bicycle Day: Commemorating First LSD Use by Lilu Anderson 24.04.2024 Swiss chemist Albert Hofmann first synthesized LSD in the 1930s. While research eventually halted, the drug is now being decriminalized ...
US Court Rules Cops Can Force Suspect to Unlock Phone by Lilu Anderson 23.04.2024 The US Court of Appeals ruled that forcing someone to use their biometrics to unlock a phone is not testimonial. ...
Hugging Face Benchmark Tests Generative AI on Health Tasks by Lilu Anderson 23.04.2024 The Open Medical-LLM leaderboard offers valuable insights into AI-related medical devices, although none of the approved devices use generative AI.
23andMe CEO Considers Taking DNA Tester Private by Mark Eisenberg 19.04.2024 The personalized DNA revolution falls short as a company's stock plummets by 90%. Valued at $3.5 billion, it seeks potential ...
2 Monster Growth Stocks with Huge Potential in 2024 by Mark Eisenberg 08.04.2024 Consider investing in AbbVie and e.l.f., two names with significant growth potential in 2024. AbbVie shines as a quality business ...
America’s FDA Settles Lawsuit Over Ivermectin Warnings by Mark Eisenberg 05.04.2024 A lawsuit is underway as the misuse of #ivermectin as a COVID treatment continues. The article discusses the legal ramifications ...